0

544529

APPL

img img img img
No Data Available

Aptus Pharma Ltd Share Price Update

As of the latest trading session, Aptus Pharma Ltd share price is currently at ₹241.65, which is up by ₹4.69 from its previous closing. Today, the stock has fluctuated between ₹241.65 and ₹241.65. Over the past year, Aptus Pharma Ltd has achieved a return of [-]%. In the last month alone, the return has been 6.73%.

Investment Returns

Over 1 Month [-]% Over 3 Months [-]% Over 6 Months [-]% Over 1 Year 0.00%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

Aptus Pharma Ltd fundamentals


  • Market cap (Cr)

    [-]

  • P/E Ratio (TTM)

    [-]

  • Beta

    [-]

  • Book Value / share

    [-]

  • Return on equity

    [-]%

  • EPS (TTM)

    [-]

  • Dividend yield

    [-]%

  • Net profit/quarter (Cr)

    [-]

info icon alternate text
  • Market cap (Cr)

    165.80

  • P/E Ratio (TTM)

    0.00

  • Beta

    0.23

  • Book Value / share

    29.13

  • Return on equity

    70.94%

  • EPS (TTM)

    0.00

  • Dividend yield

    [-]%

  • Net profit/quarter (Cr)

    0.00

info icon alternate text

Aptus Pharma Ltd Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars MAR 2025 (Values in Cr)
Revenue 24.56
Operating Expense 20.54
Net Profit 2.96
Net Profit Margin (%) 12.05
Earnings Per Share (EPS) 6.08
EBITDA 4.82
Effective Tax Rate (%) 27.80
Particulars MAR 2024 (Values in Cr)
Revenue 17.86
Operating Expense 16.77
Net Profit 0.80
Net Profit Margin (%) 4.47
Earnings Per Share (EPS) 26.60
EBITDA 1.57
Effective Tax Rate (%) 28.57
Particulars MAR 2023 (Values in Cr)
Revenue 13.90
Operating Expense 13.60
Net Profit 0.19
Net Profit Margin (%) 1.36
Earnings Per Share (EPS) 6.48
EBITDA 0.62
Effective Tax Rate (%) 33.33
Particulars MAR 2025 (Values in Cr)
Book Value / Share 13.93
ROE % 70.94
ROCE % 37.63
Total Debt to Total Equity 1.79
EBITDA Margin 20.07
Particulars MAR 2024 (Values in Cr)
Book Value / Share 58.88
ROE % 58.39
ROCE % 25.83
Total Debt to Total Equity 2.74
EBITDA Margin 8.79
Particulars MAR 2023 (Values in Cr)
Book Value / Share 32.28
ROE % 19.59
ROCE % 13.07
Total Debt to Total Equity 2.28
EBITDA Margin 4.46
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 5.21
Total Assets 21.91
Total Liabilities 21.91
Total Equity 6.96
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) 14.14
Return on Capital (%) 17.89
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.91
Total Assets 10.02
Total Liabilities 10.02
Total Equity 1.76
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) 7.95
Return on Capital (%) 11.28
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.53
Total Assets 6.21
Total Liabilities 6.21
Total Equity 0.96
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) 3.12
Return on Capital (%) 6.11
Particulars MAR 2025 (Values in Cr)
Net Income 4.19
Cash from Operations -0.72
Cash from Investing -0.54
Cash from Financing 6.68
Net change in Cash 4.29
Free Cash Flow -0.10
Particulars MAR 2024 (Values in Cr)
Net Income 1.11
Cash from Operations -1.83
Cash from Investing -0.30
Cash from Financing 2.85
Net change in Cash 0.37
Free Cash Flow -1.50
Particulars MAR 2023 (Values in Cr)
Net Income 0.29
Cash from Operations -0.06
Cash from Investing -0.35
Cash from Financing 0.81
Net change in Cash 0.27
Free Cash Flow 0.29
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 25.93 12.71 1.34 198.71 23.12 / 52.00
BLISS GVS PHARMA LTD 218.00 20.84 2.03 2306.20 105.05 / 225.00
CIPLA LTD 1329.55 22.59 3.26 107398.48 1283.00 / 1672.20
FERMENTA BIOTECH LIMITED 312.80 10.41 2.35 920.60 219.00 / 399.00
GLAXOSMITHKLINE PHARMA LT 2666.95 44.92 26.45 45179.74 1968.00 / 3515.95
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 25.93 21.08 3.61 198.71 23.12 / 52.00
AMRUTAJAN HEALTH LTD 638.00 31.90 5.39 1844.50 548.05 / 789.95
ASTRAZENECA PHARMA IND LT 8826.70 95.45 27.61 22066.75 6501.60 / 10653.05
BLISS GVS PHARMA LTD 218.00 29.70 2.08 2306.20 105.05 / 225.00

Aptus Pharma Ltd shareholding pattern

Holding

27.11%
72.88%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

News

Left Arrow
Right Arrow

Aptus Pharma Ltd Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
241.65 1.98 redarrow
red-green-graph indicator
11 Bearish
5 Bullish
  • 5 Days 239.80
  • 26 Days 232.20
  • 10 Days 243.40
  • 50 Days 208.10
  • 12 Days 243.30
  • 100 Days 169.30
  • 20 Days 238.00
  • 200 Days 169.30
233.88 PIVOT

First Support

230.82

First Resistance

240.02

Second Support

224.68

Second Resistance

243.08

Third Support

221.62

Third Resistance

249.22

RSI

54.54

ADX

44.61

MACD

11.15

Williams % R

-78.48

Commodity Channel Index (CCI)

-51.02

Date

2026-02-06

Week

8571.00

Same Day

20000.00

Month

18727.00

1 Year

0.24

3 Year

0.21

Over 1 Month

6.73%

down

Over 1 Year

0.00%

down

Over 3 Months

40.74%

down

Over 3 Years

0.00%

down

Over 6 Months

179.29%

down

Over 5 Years

0.00%

down

Aptus Pharma Ltd Corporate Actions

Top Gainers

Aptus Pharma Ltd Share Price

Aptus Pharma Limited was originally incorporated as 'Aptus Pharma Private Limited', as a private limited company with the Registrar of Companies, Gujarat, pursuant to a Certificate of Incorporation dated August 12, 2010. Subsequently, Company was converted into a public limited retaining the name as 'Aptus Pharma Limited' and a fresh certificate of incorporation dated December 12, 2024 was issued by the Registrar of Companies, Central Processing Centre.

Company is engaged in the business of marketing, and distribution of finished pharmaceutical formulations. While the Company does not own any manufacturing facilities, it operates through a contract manufacturing model with 7 units. under various arrangements. It provide a diverse range of pharmaceutical products catering to various therapeutic categories including anti-infectives, gastrointestinal, antacids, anti-allergic and respiratory, nutritional supplements, pain management, neuro-psychiatric, cardiovascular, antidiabetic, lipid-lowering, and general wellness products. These are offered across a variety of dosage forms, such as tablets, capsules, softgels, syrups, suspensions, injections, ointments, creams, balms, drops, lotions, vials, powders, gels, and sachets.

The Company started business through 4 regional headquarters in Gujarat in 2011. It launched a portfolio of nearly 25 products targeting essential therapeutic divisions in 2013. It expanded the operations to over 50 products, catering to both acute and chronic segments in 2015. This resulted the increase in portfolio to 70 products in 2019 and to over 100 in 2022. The Company enhanced the production to over 175 products in 2024. It established 3 operational divisions: Acute, Chronic, and OTC in 2024.

Company is planning the Initial Public Issue of 20,00,000 equity shares of face value of Rs 10 each through fresh issue.

Parent organization Indian Private
NSE symbol [-]
Founded 2010
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Aptus Pharma Ltd?

Answer Field

Aptus Pharma Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 241.65 as on Feb 13 2026 10:15 AM.

What is the Market Cap of Aptus Pharma Ltd Share?

Answer Field

The market cap of Aptus Pharma Ltd for NSE ₹ 0.00 & for BSE ₹ 165.80 as on Feb 13 2026 10:15 AM.

What is the 52 Week High and Low of Aptus Pharma Ltd?

Answer Field

The 52 Week High and Low of Aptus Pharma Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 270.50 and ₹ 80.80.

What is 1 year return for Aptus Pharma Ltd?

Answer Field

The 1 year returns on the stock has been 0.00%.

What is the P/E Ratio of Aptus Pharma Ltd Share?

Answer Field

As on Feb 13 2026 10:15 AM the price-to-earnings (PE) ratio for Aptus Pharma Ltd share is 0.00.

What is the PB ratio of Aptus Pharma Ltd Share?

Answer Field

As on Feb 13 2026 10:15 AM, the price-to-book (PB) ratio for Aptus Pharma Ltd share is 29.13.

How to Buy Aptus Pharma Ltd Share?

Answer Field

You can trade in Aptus Pharma Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Aptus Pharma Ltd Share on Bajaj Broking App?

Answer Field

To buy Aptus Pharma Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Aptus Pharma Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image

Get Free Demat Account*

+91
close-img

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59